The University of Texas - MD Anderson Cancer Center - Infectious Diseases
About The University of Texas - MD Anderson Cancer Center - Infectious Diseases
The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the U.S. and one of the original three comprehensive cancer centers in the country.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The University of Texas - MD Anderson Cancer Center - Infectious Diseases
During the past decade, The University of Texas - MD Anderson Cancer Center - Infectious Diseases conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
2010-06-22
2018-07-06
Completed
508
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
2011-05-24
2017-03-13
Completed
74
Quality Study of Anesthetic Technique on Breast Cancer Surgery
2012-01-01
2013-06-01
Completed
101
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
2011-12-01
2019-08-01
Completed
349
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
2013-10-14
2021-03-05
Completed
431
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at The University of Texas - MD Anderson Cancer Center - Infectious Diseases
According to Clinical.Site data, the most researched conditions in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" are
"Cytomegalovirus Infection" (1 trials), "Influenza" (1 trials) and "Staphylococcal Bacteraemia" (1 trials). Many other conditions were trialed in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" in a lesser frequency.
Clinical Trials Intervention Types at The University of Texas - MD Anderson Cancer Center - Infectious Diseases
Most popular intervention types in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" are "Biological" (1 trials), "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cefazolin" (1 trials), "DBS Self-Collection Kit" (1 trials), "Dalbavancin" (1 trials), "Daptomycin" (1 trials) and "Nafcillin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The University of Texas - MD Anderson Cancer Center - Infectious Diseases
The vast majority of trials in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases" are
3 trials for "All" genders.
Clinical Trials Status at The University of Texas - MD Anderson Cancer Center - Infectious Diseases
Currently, there are NaN active trials in "The University of Texas - MD Anderson Cancer Center - Infectious Diseases".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in The University of Texas - MD Anderson Cancer Center - Infectious Diseases,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The University of Texas - MD Anderson Cancer Center - Infectious Diseases, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".